Siemens Healthcare Diagnostics has introduced the Advia Chemistry Cardiophase hsCRP assay, consolidating specialist cardiac testing onto routine high-throughput analysis.
The assay is qualified for independent cardiac risk assessment, as well as cardiac risk stratification.
The results are said to exhibit excellent correlation and similar performance to the industry gold-standard method, which is the Siemens BNII Nephelometer.
Cardiophase hsCRP is available on a range of solutions from Siemens, including options for chemistry and immunology laboratories, and point-of-care settings.
